Effects of different arginine concentrations on angiogenic protein production induced by HeLa cells

Nutrition

Volumn 26, Issue 7-8, 2010, Pages 818-822

  Chou, Szu Yuan ^a   Hsu, Chun Sen ^a   Hsu, Ming Yi ^a   Liang, So Jung ^a   Yeh, Chiu Li ^b   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Angiogenic protein; Arginine; CD51 CD61; Endothelial cells; HeLa cells; Inducible nitric oxide

Indexed keywords

ANGIOGENIC PROTEIN; ARGININE; BASIC FIBROBLAST GROWTH FACTOR; CD51 ANTIGEN; CD61 ANTIGEN; GELATINASE A; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANGIOGENIC PROTEINS; ARGININE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HELA CELLS; HUMANS; INTEGRIN ALPHAV; INTEGRIN BETA3; MATRIX METALLOPROTEINASE 2; NITRIC OXIDE SYNTHASE TYPE II; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953811229     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.08.004     Document Type: Article

References (39)

1. de Jonge W.J., Marescau B., D'Hooge R., De Deyn P.P., Hallemeesch M.M., Deutz N.E., et al. Overexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in mice. J Nutr 2001, 131:2732-2740.
2. Barbul A., Lazarou S.A., Efron D.T., Wasserkrug H.L., Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 1990, 108:331-336.
3. Yeh C.L., Lee C.H., Chen S.C., Hou Y.C., Yeh S.L. Effects of arginine-containing total parenteral nutrition on N balance and phagocytic activity in rats undergoing a partial gastrectomy. Br J Nutr 2005, 93:267-272.
4. Gianotti L., Alexander J.W., Pyles T., Fukushima R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 1993, 217:644-653.
5. Evoy D., Lieberman M.D., Fahey T.J., Daly J.M. Immunonutrition: the role of arginine. Nutrition 1998, 14:611-617.
6. De-Souza D.A., Greene L.J. Pharmacological nutrition after burn injury. J Nutr 1998, 128:797-803.
7. Kirk S.J., Regan M.C., Wasserkrug H.L., Sodeyama M., Barbul A. Arginine enhances T-cell responses in athymic nude mice. JPEN 1992, 16:429-432.
8. Ochoa J.B., Bernard A.C., Mistry S.K., Morris S.M., Figert P.L., Maley M.E., et al. Trauma increases extrahepatic arginase activity. Surgery 2000, 127:419-426.
9. Gattinoni L., Powell D.J., Rosenberg S.A., Restifo N.P. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 2006, 6:383-393.
10. Casas-Rodera P., Gomez-Candela C., Benitez S., Mateo R., Armero M., Castillo R., et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial. Nutr Hosp 2008, 23:105-110.
11. Park K.G., Heys S.D., Blessing K., Kelly P., McNurlan M.A., Eremin O., et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) 1992, 82:413-417.
12. Philip R., Campbell E., Wheatley D.N. Arginine deprivation, growth inhibition and tumor cell death: 2. enzymatic degradation of arginine in normal and malignant cell cultures. Br J Cancer 2003, 88:613-623.
13. Wheatley D.N., Philip R., Campbell E. Arginine deprivation, and tumor cell death: arginase and its inhibition. Mol Cell Biochem 2003, 244:177-185.
14. Fukumura D., Yonei Y., Kurose I., Saito H., Ohishi T., Higuchi H., et al. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo. Hepatology 1996, 24:141-149.
15. Cifone M.G., Festuccia C., Cironi L., Cavallo G., Chessa M.A., Pensa V., et al. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 1994, 157:181-194.
16. Mordan L.J., Burnett T.S., Zhang L.X., Tom J., Cooney R.V. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 1993, 14:1555-1559.
17. Gottke M., Chadee K. Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells. Inflamm Res 1996, 45:209-212.
18. Department of Health, Taiwan. Top 10 leading causes of death in Taiwan; 2009. Available at: http://www.doh.gov.tw.
19. Vissers Y.L., Dejong C.H., Luiking Y.C., Fearon K.C., von Meyenfeldt M.F., Deutz N.E. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?. Am J Clin Nutr 2005, 81:1142-1146.
20. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994, 54:1352-1354.
21. Wheatley D.N., Scott L., Lamb J., Smith S. Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem 2000, 10:37-55.
22. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 1997, 57:3300-3304.
23. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
24. Malinda K.M., Sidhu G.S., Banaudha K.K., Gaddipati J.P., Maheshwari R.K., Goldstein A.L., et al. Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol 1998, 160:1001-1006.
25. Efron D., Barbul A. Role of arginine in immunonutrition. J Gastroenterol 2000, 35(suppl 12):20-23.
26. Braga M., Gianotti L., Vignali A., Carlo V.D. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002, 132:805-814.
27. Rose D.P., Connolly J.M. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 2000, 37:119-127.
28. Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., Murray J.C. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997, 76:1410-1415.
29. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., Ferrara N., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92(suppl). II365-71.
30. Messina E.J., Weiner R., Kaley G. Prostaglandins and local circulatory control. Fed Proc 1976, 35:2367-2375.
31. 2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci 1998, 39:581-591.
32. Vihinen P., Kahari V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166.
33. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264:569-571.
34. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998, 4:623-626.
35. Ma Q., Wang Y., Gao X., Ma Z., Song Z. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma. Clin Cancer Res 2007, 13:7407-7412.
36. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995, 92:4392-4396.
37. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19:711-721.
38. Montrucchio G., Lupia E., de Martino A., Battaglia E., Arese M., Tizzani A., et al. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am J Pathol 1997, 151:557-563.
39. Maeda H., Noguchi Y., Sato K., Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994, 85:331-334.